even those w/ a 10% weight loss (many would presumptively have T2D remission) at 1 yr had a 20% RRR in MACE --> a significant value which supports notion that T2D remission would likely lower events (still points toward residual risk) https://doi.org/10.1016/S2213-8587(16)30162-0 …
I'm not sure I follow. The evidence for paid vs non healthcare and compliance is fairly mixed, and Virta is mostly billing insurance companies rather than patients directly from my understanding anyway
-
-
I haven't seen any numbers on how many are covered by insurance and how many are paying out of their own pocket I did however find in their faq that "Most of our existing patients are covered through their employer-sponsored health plans". So sounds like you're "more right"

-
Perhaps those who fancy the Virta approach and paying for their own treatment could economise by just buying 6 months worth? That is where the best results are found - then it goes downhill again..https://twitter.com/Alan_Watson_/status/1131119398977179649 …
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.